Veterinary Medicines

Pentium forte plus vet. injeksjonsvæske, emulsjon, vaksine til atlantisk laks

Authorised
  • Aeromonas salmonicida, Inactivated
  • Vibrio anguillarum, serotype O1, Inactivated
  • Vibrio anguillarum, serotype O2A, Inactivated
  • Moritella viscosa, Inactivated
  • Aliivibrio salmonicida, Inactivated
  • Infectious pancreatic necrosis virus, Inactivated
Download as PDF

Product identification

Medicine name:
Pentium forte plus vet. injeksjonsvæske, emulsjon, vaksine til atlantisk laks
Active substance:
  • Aeromonas salmonicida, Inactivated
  • Vibrio anguillarum, serotype O1, Inactivated
  • Vibrio anguillarum, serotype O2A, Inactivated
  • Moritella viscosa, Inactivated
  • Aliivibrio salmonicida, Inactivated
  • Infectious pancreatic necrosis virus, Inactivated
Target species:
  • Atlantic salmon
Route of administration:
  • Intraperitoneal use

Product details

Active substance and strength:
  • Aeromonas salmonicida, Inactivated
    70.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Vibrio anguillarum, serotype O1, Inactivated
    75.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Vibrio anguillarum, serotype O2A, Inactivated
    75.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Moritella viscosa, Inactivated
    70.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Aliivibrio salmonicida, Inactivated
    90.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Infectious pancreatic necrosis virus, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    0.10
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Atlantic salmon
      • Fish meat
        0
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI10AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Animal Health GmbH
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 07-4936
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 31/01/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 1/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."